The Journal of dermatological treatment · 2006
Short-term oral isotretinoin therapy does not cause clinical or subclinical peripheral neuropathy.
Клиническое исследованиеСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chroni Elisabeth, Pasmatzi Efi, Monastirli Alexandra, Georgiou Sophia, Katsoulas George, Polychronopoulos Panayiotis, Tsambaos Dionysios
Аннотация
BACKGROUND: Subclinical neurophysiologic abnormalities mainly suggestive of sensory fibers dysfunction were observed in some patients after 1 and 3 months of treatment with oral acitretin. Moreover, two cases of peripheral sensory neuropathy and one of sensorimotor polyneuropathy were observed after short-term oral administration of this compound.
OBJECTIVE: The objective of this prospective study was to investigate whether short-term treatment with oral isotretinoin can also affect peripheral nerve function.
METHODS: Serial neurologic and neurophysiologic examinations were performed on 18 young patients with severe nodulocystic acne prior to and 1 and 3 months after the onset of oral isotretinoin treatment (1 mg/kg per day).
RESULTS: Clinical neurologic examination before and under treatment disclosed no abnormalities in any of the patients. There were no significant differences between the pre- and post-treatment neurophysiologic parameters. Furthermore, evaluation of the serial neurophysiologic measurements in each patient separately under oral isotretinoin treatment revealed no changes fulfilling the criteria of abnormality.
CONCLUSIONS: Short-term administration of oral isotretinoin in young patients does not cause clinical or subclinical neuropathy.
OBJECTIVE: The objective of this prospective study was to investigate whether short-term treatment with oral isotretinoin can also affect peripheral nerve function.
METHODS: Serial neurologic and neurophysiologic examinations were performed on 18 young patients with severe nodulocystic acne prior to and 1 and 3 months after the onset of oral isotretinoin treatment (1 mg/kg per day).
RESULTS: Clinical neurologic examination before and under treatment disclosed no abnormalities in any of the patients. There were no significant differences between the pre- and post-treatment neurophysiologic parameters. Furthermore, evaluation of the serial neurophysiologic measurements in each patient separately under oral isotretinoin treatment revealed no changes fulfilling the criteria of abnormality.
CONCLUSIONS: Short-term administration of oral isotretinoin in young patients does not cause clinical or subclinical neuropathy.